PeptideLabs Logo
PeptideLabs
All profiles

Glutathione

Peptide · Other substances

An endogenous tripeptide and antioxidant. Product claims depend heavily on formulation and route; compounded sterile products add risks.

Not a peptide medicine
LibraryNo account · this device only

Also known as: GSH · Reduced glutathione

Use at a glance

Glutathione

An endogenous tripeptide and antioxidant. Product claims depend heavily on formulation and route; compounded sterile products add risks.

Which entry would you like to view?

Choose a source entry. Different products and study groups do not form one combined plan.

Online report · not medically verified

What amount?
250–1,000 mg
How often?
once per day
What time of day?
not reliably established
In what setting?
oral reports
How is it used?
A supplement, a substance found in the body and a medicine are not equivalent. Form and intended use matter.
Does it need mixing?
Not universally. Ready-made solutions, tablets and raw powders differ. Water does not turn raw material into a sterile medicine.
View preparationCheck sources
Overview of all entries

  • Glutathione · oral reports

    Online report · not medically verified

    250–1,000 mg · once per day · not reliably established

  • Glutathione · Liposomal / sublingual reports

    Online report · not medically verified

    300–500 mg · once per day · not reliably established

  • Glutathione · Clinic IV reports

    Online report · not medically verified

    600–1,200 mg · once per week · Time of day not stated here

More factsPeptide · Other substances
Classification
Peptide · Other substances
Research focus
An endogenous tripeptide and antioxidant. Product claims depend heavily on formulation and route; compounded sterile products add risks.
Evidence
Established
Status
Not a peptide medicine

This entry is not a single peptide, or its use depends on diagnosis, product form or composition. A blanket peptide dose would be misleading.

Schedule explained in detailNo uniform peptide protocol

Amount status

Community source: oral 250–1,000 mg/day, liposomal/sublingual roughly 300–500 mg/day; clinic-community sources cite IV 600–1,200 mg per weekly session. No approved IV/SC wellness dose.

Profile evidence level: established.

Timing

Timing is route- and product-dependent; sterile infusions do not belong in self-administration.

No individual recommendation.

Cycle/duration

Cited online as 4 weeks to 6 months orally, or roughly six weekly IV sessions. Clinical outcomes remain unclear.

No individual recommendation.

External community reference availableThe external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.

External community reference available

The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.

Open community source

Mixing & calculations

Not universally. Ready-made solutions, tablets and raw powders differ. Water does not turn raw material into a sterile medicine.

See calculation examplesFollow sample figures to understand mg, ml and scale markings.

Documented vial and fluid examples

The table shows only the arithmetic for explicitly stated inputs. It confirms neither vial content nor stability, sterility or an appropriate target amount.

1,200 mg · assumed final volume: 3 ml

Community calculation example
Calculated amount40 mg
Concentration400,000 µg/ml
U-10010 U
Volume0.1 ml
All preparation informationProduct details and calculation examples from the available sources.

Pure arithmetic from the reference: exactly 1,200 mg +3 ml =400 mg/ml, 10 U =40 mg. This is not an approved injectable dose; the FDA documented endotoxin/sterility problems with sterile compounding.

Reconstitution & quantitiesOpen basics, units and sources
Explained in very simple termsBefore reading any number: this page reports what a product label, study or online community states. It does not say what any person should use.

Amount

mg or µg describe the mass of a substance. That is not the same as ml of fluid or U on a syringe. The number is only the amount stated by the identified source.

Interval

The interval only describes the time stated between two points. For example, once every 7 days does not mean daily and never justifies catching up or doubling.

Cycle

A cycle is a stated period that may include breaks. A community cycle proves neither effectiveness nor safety and does not prevent long-term risks.

Reconstitution

Reconstitution means mixing powder with a defined volume of fluid. This changes concentration, not the total amount in the vial. On U-100, 100 U equals exactly 1 ml of volume.

Not a guide to misuse

All community figures are shown only to place widely circulated online protocols in context. They are not instructions for self-use, injection, performance enhancement or any other misuse. Approved figures apply only to the exact named product, approved indication and medical supervision.

Research, risks & more detailsMechanism, adverse effects, storage, comparisons and common questions.

Mechanism: what is supported and what does not follow

Endogenous tripeptide central to cellular redox chemistry

Glutathione is classified as “Endogenous tripeptide central to cellular redox chemistry”. An endogenous tripeptide and antioxidant. Product claims depend heavily on formulation and route; compounded sterile products add risks. This describes the investigated pathway but does not validate a community use, amount, route or combination.

01

Glutathione redox biology

This studies the role of glutathione as the body's own antioxidant, protecting cells from oxidative stress, similar to an internal cleaning system. Glutathione levels and oxidation markers are measured in blood or cell samples.

02

Redox cofactor biology

This concerns substances acting as helper molecules in cellular energy and repair reactions, similar to a tool that supports many different chemical reactions. Enzyme activity and cell energy markers are measured in the lab.

03

Tripeptide fragment

This examines the function of a very short building block made of only three amino acids, comparable to a very short word within a long sentence. Cell signalling or binding behaviour in the lab is typically measured.

What communities discuss

These themes describe discussions and vendor claims. They do not prove benefit, safety, product identity or suitable use.

Anti-aging forums

Combinations of growth-axis, mitochondrial, and skin peptides are compared here with the goal of influencing visible or felt signs of ageing, often documented personally over years. Anecdotes and vendor advertising about slowed ageing are not scientific proof.

General wellness forums

Broader wellbeing impressions such as mood, sleep, and general feeling after using various products are exchanged here, usually without structured tracking. Such general impressions are not a substitute for targeted clinical examination.

Compounding pharmacy discussion

This compares how individually prepared products from different compounding pharmacies differ in purity, concentration, and handling. Such comparisons are usually based on individual cases and do not replace standardised quality testing.

Adverse effects and safety risks

  • Risks depend particularly on actual identity, dosage form, concentration, excipients and medical rationale. Vitamins, cofactors and diluents can also cause adverse effects or interactions.
  • Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
  • A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.

Do not self-use / obtain clinical review

  • Allergy, kidney/liver disease, pregnancy, relevant medicines, and absent diagnosis or product identity must be resolved before use.
  • Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
  • Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.

Monitoring and laboratory markers

  • Monitoring follows the specific medical purpose, such as confirming deficiency, organ function or tolerability. A blanket peptide lab panel is not meaningful.
  • Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.

Evidence boundary

Established

Product claims depend heavily on formulation and product form; compounded sterile products add risks.

Clinical evidence

The described biological role is well established, or extensive regulator-reviewed human data exist for clearly defined products and uses. This does not automatically transfer to other products or purposes.

Glutathione is an endogenous tripeptide with an established redox role, unlike synthetic research peptides without a physiological role.

Storage and stability

  • The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
  • Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
  • Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.

Troubleshooting and common errors

  • U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
  • Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
  • Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
  • Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.

Regulatory status and WADA

Not a peptide medicine

This is not a standalone peptide active; product form and regulatory status need separate consideration.

WADA 2026

The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.

WADA — 2026 Prohibited List

Combinations / stacks

  • Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
  • Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
  • Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.

Frequently asked questions

Is an amount shown here a recommendation?

No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.

Does the U-100 calculator prove correct use?

No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.

Can this profile be combined with other substances?

Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.

Which source controls when information conflicts?

For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.

Are community claims clinical evidence?

No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.

Back to all 64 profilesOpen scientific atlas profile